Having trouble viewing this email? Click here.
 
A SPECIAL
ANNOUNCEMENT FROM:
  BioPharm Logo  
 
GPEx® (Gene Product Expression) technology is a Catalent proprietary technology that offers several distinct advantages over other conventional gene insertion methods including:
Related topics
Faster timelines - From cDNA to milligram quantities of antibody in 90 days; from cDNA to MCB candidate in 5 months

 Better performance - Higher expression levels with unmatched genetic stablility

 Increased flexibility - Cell lines for protein analysis through commercial manufacturing

 Unique versatility - No need for selectable markers; GPEx®technology can be applied to single-gene or multigenic expression applications
Come see us at the AAPS National Biotech Conference, May 16-18, Booth #44

Come visit us at BIO 2011! June 27-30, Booth # 1843
We guarantee GPEx®technology can engineer an
un-selected cell pool expressing your monoclonal antibody at a 1g/L or higher level in 90 days from the receipt of your cDNA, or your initial cell line development is free. Offer ends September 15, 2011.
 
  
*Certain terms and conditions apply. This guarantee is subject to the terms and conditions of the GPEx initial cell line development service agreement, including agreed upon success criteria, to be entered into by the parties, and is not transferable. Additional development services such as delivery of an actual cell line and purified proteins require a separate development agreement and free structure. Offer is limited to initial cell line development service agreements executed after May 1,2011.
To unsubscribe or manage your subscriptions, please click here.
For more information call +1-866-720-3148, Email us at sales@catalent.com, or visit www.catalent.com

Catalent Pharma Solutions respects your privacy.
©Copyright 2011, Catalent Pharma Solutions, Inc. 14 Schoolhouse R, Somerset, NJ 08873. All rights reserved.

BioPharm International is published by Advanstar Communications, 485 Rt 1 South, Iselin, NJ 08830.
This is an advertisement sent on behalf of this advertiser.

 

 

Brochure whitepaper Application Notes Downloads